Lehman Brothers research : an analyst decides that the market overreacted to Merck's Vioxx woes /
In September 2004, Merck announced a voluntary withdrawal of Vioxx, one of its top earning drugs, after a new study suggested that it increased the risk of heart attacks. In only a few days, Merck's share price collapsed, and nearly $25 billion in shareholder wealth was erased. This case examin...
Main Author: | |
---|---|
Corporate Author: | |
Format: | eBook |
Language: | English |
Published: |
[London] :
SAGE,
2016.
|
Series: | SAGE knowledge. Cases.
|
Subjects: | |
Online Access: | Connect to the full text of this electronic book |
Internet
Connect to the full text of this electronic bookAvailable Online
Call Number: |
HG4529 |
|
---|---|---|
Call Number | Status | Get It |
HG4529 | Available |